|
Diabetics Articles | Diabetics Links | Diabetics Partners | Diabetics Sitemap |
|
|
Diabetic Cooking
Diabetic Diet Plan
Diabetic Food Pyramid
Diabetic Food
Diabetic Ketoacidosis
Diabetic Neuropathy
Diabetic Retinopathy
Diabetic Shoes
Diabetic Supply Testing
Diabetic Symptoms
|
Index of All Articles in the Diabetic Food Pyramid Category
Defined Tag: Diabetic Food Pyramid
How To Use The Diabetic Food Pyramid
You ve most probably heard the statement we are what we eat This is especially true for diabetic patients whose dietary needs are quite different from the normal necessities of people Diabetic patients have a difficult time metabolizing sugar Diabetes,
Read More...
|
|
|
Diabetics News and Events
|
|
Diabetic Neuropathy News
CEBIX Raises $14.0M
Wed, 01 Sep 2010 05:53:32 -0700 La Jolla-based Cebix, a developer of treatments for type 1 diabetic neuropathy, has raised $14.0M in a new funding round, according to a regulatory filing by the firm today. Details on the funding have not been announced by the company, however, the filing indicates that Sofinnova Venture Partners, InterWest Partners, Thomas McNerney & Partners, and Creative Peptides Sweden are all now ...
| Research and Markets: Target Product Profiles 2010: Physician Insights on Key Attributes: Diabetic Neuropathy
Mon, 30 Aug 2010 05:35:44 -0700 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9846c1/target_product_pro) has announced the addition of Decision Resources, Inc.'s new report "Target Product Profiles 2010: Physician Insights on Key Attributes: Diabetic Neuropathy" to their offering. Diabetic Neuropathy: An agent that has disease-modification potential for the ...
| Eisai to Launch Rapid-acting Insulin Secretagogue Glufast(R) in China
Fri, 03 Sep 2010 02:18:48 -0700 Tokyo, Sept 3, 2010 - (JCN Newswire) - Eisai Co., Ltd. announced today that it launched Glufast(R) (Chinese brand name: Kuai ru tuo, generic name: mitiglinide calcium hydrate), a rapid-acting insulin secretagogue, in China on September 1. Glufast is a phenylalanine derived rapid-acting insulin secretagogue originally discovered and developed by Kissei Pharmaceutical Co., Ltd.
|
|
|
|
© 2010, Diabetics - All Rights Reserved Worldwide | Diabetics Legal Information |